Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 35/100

Failure Rate

0.0%

0 terminated/withdrawn out of 6 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

17%

1 trials in Phase 3/4

Results Transparency

0%

0 of 6 completed trials have results

Key Signals

Enrollment Performance

Analytics

N/A
2(50.0%)
Phase 4
1(25.0%)
Phase 2
1(25.0%)
4Total
N/A(2)
Phase 4(1)
Phase 2(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (6)

Showing 6 of 6 trials
NCT06433440Phase 4Completed

Safety and Immunogenicity of Purified Verocell Rabies Vaccine PVRV Administered Intramuscularly and Intradermally

Role: lead

NCT06188728Not ApplicableCompleted

Husk Fiber Intervention on Metabolic Health of Centrally Obese School Teachers

Role: lead

NCT05574569Not ApplicableCompleted

Cognitive Behavior Play Therapy and Culturally Adapted Mindfulness-Based Guided Self-Help for Parents

Role: collaborator

NCT03651102Phase 2Completed

Efficacy and Safety of Low Dose Thalidomide in Transfusion Dependent Thalassemia

Role: collaborator

NCT04311359Completed

A Pharmacovigilance Study of Brain Oedema

Role: lead

NCT04293432Completed

A Pharmacovigilance Study of Torsade de Pointes

Role: lead

All 6 trials loaded